There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better ...

Aortic stenosis is a heart valve disease that some people don't realize they have. So what is it, how is it treated?

The AMEND Transcatheter Mitral Valve Annuloplasty System: Early Human ... Presentation NY Valves 2025. Transcatheter Treatment of Chronic Aortic Regurgitation with the J-Valve TAVR System: EFS Results ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Researchers at the University of California, Irvine have successfully performed preclinical laboratory testing of a ...

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

Gore & Associates announced that the company’s TAG thoracic branch endoprosthesis (TBE) has received FDA approval for us ...

The prevalence of aortic stenosis (AS) and amyloid transthyretin cardiomyopathy (ATTR‐CM) increases with age. While the global prevalence of calcific aortic valve disease is estimated to be >2% in ...

ABSTRACT. Introduction: The clinical significance of new-onset left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) remains controversial.In the presented study, we ...

For the estimated 1.6 million Americans diagnosed with symptomatic tricuspid valve regurgitation each year, a significant ...

Background—Few studies have explored the long-term function of cryopreserved homograft valves used for reconstruction of the right ventricular tract (RVOT) in patients with congenital heart disease.